Bullous fixed drug eruption due to erlotinib: A rare case report
Fixed Drug Eruption is one of the most common cutaneous adverse drug reactions, of which the bullous variant is a more severe form. Epidermal growth factor (EGFR) inhibitors are one of the prime chemotherapeutic agents used recently in various malignancies. Most of the side effects of EGFR inhibitor...
Saved in:
| Main Authors: | Kallolinee Samal, Manoj Kumar Nayak, Srigopal Mohanty, Nibedita Dixit |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Series: | Annals of Oncology Research and Therapy |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/aort.aort_36_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fixed drug eruption – A retrospective review of 146 patients in a tertiary hospital in Southern Taiwan
by: Jui-Wen Yeh, et al.
Published: (2025-04-01) -
Cross-Reactivity: a Case of Paracetamol-Induced Generalized Bullous Fixed Drug Eruption Followed by Dipyrone-Induced Fixed Drug Eruption
by: Wang Y, et al.
Published: (2025-04-01) -
Generalized bullous fixed drug eruption induced by chlordiazepoxide: a case report of a potentially lethal adverse effect
by: Rishabh Singh, et al.
Published: (2025-04-01) -
Ofloxacin-induced Fixed Drug Eruptions
by: Kushalkumar H. Gohel, et al.
Published: (2020-01-01) -
Semaglutide-induced fixed drug eruption
by: Sahithi Talasila, BS, et al.
Published: (2025-02-01)